EDIT vs PDD · rev $32.3M vs P/E 8.4, rev $61.75B
Editas Medicine Inc (EDIT) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
EDIT currently screens at market cap $375.2M. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the EDIT and PDD stock pages for the full models.
Not investment advice.